MAY 21, 2018
For SPMS Treatment, Fat-Derived Stem Cells Safe, Feasible, Trial Shows
This was not the same-day fast derived low-dose stem cell treatment that is available at U.S. clinics. It was lab expanded autologus fat derived stem cells cultured in a lab to high dose.
This study was triple-blind, placebo-controlled study, using expanded high dose MSCs from fat, exactly like Celltex does. 12 month followup concluded it was safe. Unfortunately the study was only examining safety, not effectiveness. But at least it is more evidence.
It was dose by multiple universities across Spain, and published in a high quality journal PLOS One.
Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study
The only way patients can access this type of therapy at this time is through Celltex in Houston TX, but then you have to go to Cancun MX to receive the treatment.
For SPMS Treatment, Fat-Derived Stem Cells Safe, Feasible, Trial Shows
This was not the same-day fast derived low-dose stem cell treatment that is available at U.S. clinics. It was lab expanded autologus fat derived stem cells cultured in a lab to high dose.
This study was triple-blind, placebo-controlled study, using expanded high dose MSCs from fat, exactly like Celltex does. 12 month followup concluded it was safe. Unfortunately the study was only examining safety, not effectiveness. But at least it is more evidence.
It was dose by multiple universities across Spain, and published in a high quality journal PLOS One.
Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study
The only way patients can access this type of therapy at this time is through Celltex in Houston TX, but then you have to go to Cancun MX to receive the treatment.